1- Rand Sutherland E, Cherniack M. Management of chronic obstructive pulmonary disease. N Engl J Med 2004; 26:
2689 – 2697.
2-Halvani A, Nadooshan H. Serum C – reactive protein level in COPD patients and noral population. Tanaffos 2007;
6:51-55.
3-Joppa P, Petrasova D, Stancak B, Tkacova R. Systemic inflammation in patients with COPD and pulmonary
Hypertension. Chest 2006; 130:326-333.
4- Rich S, Maclaughlin V. V. Pulmonary hypertension. In: Zipes D. P, Libby P, Bonow R. O , et al. Heart disease. 7th
ed . Elsevier Saunders; 2005.p.1807-1816.
5- Rich S. Pulmonary hypertension. In: Fauci A S, Kasper D, Longo D. L , et al. Principles of Internal Medicine. 17 th
ed. McGrawHill: 2008 .p.1576-1581.
6-Falk A, Kadiev S, Criner Gو Scharf SM, Minai OA, Diaz P. Cardiac disease in chronic obstructive pulmonary
disease. Proc Am Thorac Soc 2008; 5:543-548.
7-Bossone E, Dibobodini B, Mazza A, Allegra L. Pulmonary arterial hypertension. The key role of echocardiography.
Chest 2005; 127: 1836 - 1843
8-Garrod R, Barley E, Barley E, Fredericks S, Hagan G.The relationship between inflammatory markers and disability
in chronic obstructive pulmonary disease (COPD). Prim care respire J 2007; 16: 236 – 40.
9-Lee TM, Lin MS, Chang NC. Usefulness of C – reactive protein and interleukin – 6 as predictors of outcomes in
patient with chronic obstructive pulmonary disease receiving pravastalin. Am J Cardiol 2008; 101:530 – 5. Epub 2007
Dec 26.
10- De torres T, Cordoba – Lanus – E, López-Aguilar C, Muros de Fuentes M, Montejo de Garcini A Aguirre-Jaime A,
et al. C–reactive protein levels and clinically important predictive out comes in stable COPD patients. Eur Respir J
2006; 27:902 – 907.
11- Sin Doud, Paulman F. Is systemic Inflammation responsible for pulmonary hypertension in COPD? Chest 2006;
130: 310-312.
12- Barbera JA, Peinado I, Santos S. Pulmonary hypertension in chronic pulmonary disease. Eur Respir J 2003;
21:892-905.
13- Weitzenblum D, Chaouat A. Severe pulmonary hypertension in COPD. Chest 2005; 127: 1480-1482.
)